Speaker: Charlotte Teunissen

Before we forget: Early dementia diagnosis and treatment with Charlotte Teunissen

Science & Cocktails

Challenges in the clinical implementation of Alzheimer’s disease biomarkers

The MIRIADE training program: development of dementia biomarkers

Diagnosing Alzheimer’s disease using blood-based biomarkers

Using plasma biomarkers in the diagnosis of Alzheimer’s disease

Impact of blood-based biomarkers on Alzheimer’s disease treatments

Early predictive value of plasma biomarkers for amyloid positivity

Fluid biomarkers of immune function in Alzheimer’s disease

Markers of axonal damage in progressive MS

Co-designing a brain stimulation headset for people living with Alzheimer’s disease

UK Dementia Research Institute - UK DRI

Low serum contactin-1 predicts disability progression in MS

Emerging biomarkers in MS: CNTN1 and GFAP

Novel biomarkers to predict progression in MS

Thank you!

The Institute of Cancer Research, London

NfL to monitor treatment effects in MS

Which plasma biomarkers hold the most promise in Alzheimer’s Disease?

The future of biomarkers in MS: novel discoveries and defining protocols

Let’s talk about dementia

AlzheimersResearch UK

Charlotte woman shares her aging mother's battle with Alzheimer's

WCNC

Make breakthroughs possible | Behind the scenes

AlzheimersResearch UK